文献速递关节外科

非甾体抗炎药在全关节置换术中的疗效与安全性:系统综述与直接Meta分析

The Efficacy and Safety of Nonsteroidal Anti-Inflammatory Drugs in Total Joint Arthroplasty: Systematic Review and Direct Meta-Analysis.
PubMed 文献 · J Arthroplasty · 2020-05-28

该研究系统检索了2018年11月前发表的关于全关节置换术(TJA)中使用非甾体抗炎药(NSAIDs)的文献,最终纳入25篇最佳证据文章。口服选择性COX-2抑制剂、非选择性NSAIDs及静脉注射酮咯酸可安全减少初次TJA住院期间的术后疼痛和阿片类药物消耗;口服选择性COX-2 NSAID可减少全膝关节置换术(TKA)出院后的阿片类药物消耗。强证据支持使用上述药物作为TJA住院期间术后疼痛管理的辅助用药。

要点

  • 口服选择性COX-2或非选择性NSAIDs及静脉注射酮咯酸可安全减少初次TJA住院期间的术后疼痛和阿片类药物消耗。
  • 口服选择性COX-2 NSAID可减少TKA出院后的阿片类药物消耗。
  • 强证据支持上述药物作为TJA住院期间术后疼痛管理的辅助用药。

核心结论

  • 强证据支持使用口服选择性COX-2或非选择性NSAID及静脉注射酮咯酸作为辅助药物管理TJA住院期间的术后疼痛。
  • 尽管未观察到安全性问题,处方者开具NSAIDs时仍需保持警惕。

研究设计与样本

  • 系统综述与直接Meta分析,检索MEDLINE、EMBASE和Cochrane对照试验中心注册库中2018年11月前发表的关于TJA中NSAIDs的研究。
  • 对2921篇文献进行严格评估后,25篇文章代表了纳入分析的最佳可用证据。
  • 纳入研究通过直接比较和/或Meta分析(包括定性和定量异质性检验)评估NSAIDs的有效性和安全性。

主要发现

  • 口服选择性COX-2和非选择性NSAIDs及静脉注射酮咯酸可安全减少初次TJA住院期间的术后疼痛和阿片类药物消耗。
  • 口服选择性COX-2 NSAID可减少TKA出院后的阿片类药物消耗。

临床怎么用

  • 强证据支持使用口服选择性COX-2或非选择性NSAID及静脉注射酮咯酸作为辅助药物管理TJA住院期间的术后疼痛。
  • 尽管未观察到安全性问题,处方者开具NSAIDs时仍需保持警惕。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nonsteroidal anti-inflammatory drugs (NSAIDs) have become widely used to manage perioperative pain following total joint arthroplasty (TJA). The purpose of our study is to evaluate the efficacy and safety of NSAIDs in support of the combined clinical practice guidelines of the American Association of Hip and Knee Surgeons, American Academy of Orthopaedic Surgeons, Hip Society, Knee Society, and American Society of Regional Anesthesia and Pain Management. METHODS: Databases including MEDLINE, EMBASE, and the Cochrane Central Registry of Controlled Trials were searched for studies published prior to November 2018 on NSAIDs in TJA. Studies included after a systematic review evaluated through direct comparisons and/or meta-analysis, including qualitative and quantitative heterogeneity testing, to evaluate effectiveness and safety of NSAIDs. RESULTS: After critical appraisal of 2921 publications, 25 articles represented the best available evidence for inclusion in the analysis. Oral selective cyclooxygenase (COX)-2 and non-selective NSAIDs and intravenous ketorolac safely reduce postoperative pain and opioid consumption during the hospitalization for primary TJA. Administration of an oral selective COX-2 NSAID reduced postoperative opioid consumption after discharge from TKA. CONCLUSION: Strong evidence supports the use of an oral selective COX-2 or non-selective NSAID and intravenous ketorolac as adjunctive medications to manage postoperative pain during the hospitalization for TJA. Although no safety concerns were observed, prescribers need to remain vigilant when prescribing NSAIDs.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Fillingham YA, Hannon CP, Roberts KC, et al. The Efficacy and Safety of Nonsteroidal Anti-Inflammatory Drugs in Total Joint Arthroplasty: Systematic Review and Direct Meta-Analysis. J Arthroplasty. 2020. PMID: 32690428. doi:10.1016/j.arth.2020.05.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。